IFNA1 and hepatocellular carcinoma: SVR was associated with a significantly decreased risk of HCC irrespective of whether antiviral treatment was DAA‐only (adjusted hazard ratio [AHR] 0.29), DAA + IFN (AHR 0.48), or IFN‐only (AHR 0.32).